The goal of immunotherapy, researchers like Stanton say, is to
target precancerous lesions or, of course, to prevent the disease altogether.
Not exact matches
Graduate student Megan Radyk and Jason Mills, MD, PhD, led a study revealing that although many cancer therapies
target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming
precancerous lesions.
CFSs now appear as preferential
targets for oncogene - induced replication stress in
precancerous lesions, which suggests that their instability promotes oncogenesis from early stages of the process.